DRUG STUDY

Student’s name: Date of Submission : September 26, 2008

Area : Clinical Instructor :
Patient’s name : L. B. P. Physician :
Room/bed No. : OB Ward Date of Admission : August 8, 2008
Age : 36 years old Hospital No. :

GENERIC BRAND CLASSI- MECHANISM CONTRA- SIDE EFFECTS HOW DOSAGE NURSING
NAME NAME FICATION OF ACTION INDICATION SUPPLIED AND RESPONSIBILITIES
FREQUENCY

Ferrous Sorbifer Antiane- Iron is Hemoside- GI: Tablets: 1 tab OD Before:

Sulfate mic absorbed rosis, Constipation, 325 mg P.O. -Perform hand
from the hemoch- gastric washing
duodenum romatosis, irritation, Drops: -Verify
and upper peptic ulcer, N&V, 75mg/0.6ml physician’s
jejunum by regional abdominal order
an active enteritis, cramps, Elixir: -Prepare
mechanism and anorexia, 220mg/5ml medication
through the ulcerative diarrhea, and
mucosal colitis, dark-colored Liquid: During :
cells where it hemolytic stools. These 300mg/5ml -Identify patient
combines anemia, effects may -Assess client
with the pyridoxine be minimized in semi-fowler’s
protein responsive by position
transferring. anemia, administering -Assess in
Iron is stored and preparations administering
in the body cirrhosis of as a coated the medication
 as the liver. tablet. to the patient
hemosiderin Use in Soluble iron -Position client
or those with preparations in comfortable
aggregated normal iron may stain the position
ferritin which balance. teeth.
is found in After:
reticuloen- -Document
dothelial administration
cells of the on medication
liver, spleen, -Assess patient
and bone 30-60 minutes
marrow. after
About two- administration
thirds of total and document
body iron is the patient’s
in the response to
circulating medication
RBCs in
hemoglobin.

(Spratto, et
al; 2008:
619)

Cefale- Pani- Cepha- Interferes Hypersen- GI: Capsules: 1 cap 500 Before:
xin xine losporin with the final sitivity to N&V, 250 mg, mg TID - Assess
step in cell cephalos- diarrhea, 333 mg, P.O. patient’s
wall porins or abdominal 500 mg, condition
formation related cramps or 750 mg -Perform hand
(inhibition of antibiotics. pain, sore washing
mucopeptide mouth or Powder for -Verify
biosynthesis) tongue, oral physician’s
, resulting in anorexia suspension order
unstable cell 125mg/5ml -Prepare
membranes Allergic: 250mg/5ml medication
that undergo Urticaria
lysis. In rashes, Tablets: During :
addition, cell pruritus, 250 mg, -Identify patient
division and fever, chills, 500 mg -Assess client
growth are joint pain, in semi-fowler’s
inhibited. chills, Tablets for position
myalgia oral -Assess in
(Spratto, et suspension administering
al; 2008: Hematologic: 125 mg, the medication
278) Leukopenia, 250 mg to the patient
neutropenia, -Position client
eosinophilia in comfortable
position
CNS:
Headache, After:
malaise, -Document
fatigue, administration
dizziness, on medication
confusion -Assess patient
30-60 minutes
Hepatic: after
Hepatome- administration
galy, hepatitis and document
the patient’s
response to
medication
Mefe- Pon- Non- Possesses Hypersensit Capsules: 1 cap 500 Before:
namic stan steroidal anti- ivity to GI: 250 mg mg every - Assess
acid anti- inflammatory ketorolac; Peptic ulcer, 6 hours patient’s
infla- , antipyretic individuals GI bleeding, P.O condition
mmatory and with nausea, -Perform hand
drug analgesic complete or diarrhea, washing
properties. partial constipation, -Verify
Known to syndrome abdominal physician’s
inhibit both of nasal pain, order
prostaglandi polyps, anorexia, -Prepare
n and angio- vomiting, medication
leukotriene edema, stomatitis
synthesis, to and During :
have broncho- CNS: -Identify patient
antibradyki- spastic Headache -Assess client
nin activity reaction to in semi-fowler’s
and to aspirin CV: position
stabilize Peripheral -Assess in
lysosomal edema, fluid administering
membranes. retention the medication
to the patient
(Spratto, et
al; 2008: After:
1845) -Document
-Assess patient
30-60 mins.
after
administration
and document
response to
medication
 Before:
Mother: - Assess
CV: patient’s
Cardiac Injection: condition
Pitocin arrhythmia, 10 units/ml -Perform hand
Oxytocin Acts on Hypersensit hypertensive washing
Oxytocic smooth ivity to drug. episodes -Verify
drug muscle of Significant physician’s
the uterus to cephalopelv GI: order
stimulate ic N&V, -Prepare
contractions: disproportio abdominal medication
response n; pain,
depends on unfavorable cramping During :
the uterine fetal -Identify patient
threshold of positions or CNS: . -Assess client
excitability. It presentatio headache, in semi-fowler’s
is selective ns that are dizziness position
for the undeliverabl -Assess in
uterus, e without GU: administering
especially conversion Pelvic the medication
toward the prior to hematoma, to the patient
end of delivery. post-partum -Position client
pregnancy, hemorrhage in comfortable
during labor, position
and Fetus:
immediately CV: After:
following Bradycardia, -Document
delivery. arrythmias administration
Oxytocin on medication
stimulates CNS: -Assess patient
rhythmic Permanent 30-60 minutes
contractions CNS or brain after
of the uterus, damage, administration
increases neonatal and document
the seizures the patient’s
frequency of response to
existing medication
contractions GI:
and raises Peptic ulcer,
the tone of GI bleeding,
uterine nausea,
musculature. diarrhea,
constipation,
(Spratto, et abdominal
al; 2008: pain,
1181) anorexia,
vomiting,
stomatitis

CNS:
Headache

CV:
Peripheral
edema, fluid
retention